ESCO TECHNOLOGIES INCESEEarnings & Financial Report
NYSE · life sciences
Esco is a Singaporean brand that develops, manufactures, and sells products and services for laboratories.
NextMay 9, 2026
ESE Q1 2026 Key Financial Metrics
Revenue
$289.7M
Gross Profit
$119.9M
Operating Profit
$38.4M
Net Profit
$28.7M
Gross Margin
41.4%
Operating Margin
13.2%
Net Margin
9.9%
YoY Growth
17.3%
EPS
$1.11
Financial Flow
ESCO TECHNOLOGIES INC Q1 2026 Financial Summary
ESCO TECHNOLOGIES INC reported revenue of $289.7M for Q1 2026, with a net profit of $28.7M (9.9% margin). Cost of goods sold was $169.7M, operating expenses totaled $81.6M.
Key Financial Metrics
| Total Revenue | $289.7M |
|---|---|
| Net Profit | $28.7M |
| Gross Margin | 41.4% |
| Operating Margin | 13.2% |
| Report Period | Q1 2026 |
ESCO TECHNOLOGIES INC Annual Revenue by Year
ESCO TECHNOLOGIES INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.1B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.1B |
| 2024 | $1.0B |
| 2023 | $956.0M |
| 2022 | $857.5M |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $249.1M | $260.8M | $298.5M | $247.0M | $265.5M | $296.3M | $286.5M | $289.7M |
| YoY Growth | 8.7% | 4.8% | 9.5% | 13.2% | 6.6% | 13.6% | -4.0% | 17.3% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.78B | $1.81B | $1.84B | $1.80B | $1.82B | $2.53B | $2.41B | $2.40B |
| Liabilities | $617.8M | $617.4M | $601.3M | $558.1M | $538.3M | $1.20B | $869.5M | $838.1M |
| Equity | $1.17B | $1.19B | $1.24B | $1.24B | $1.28B | $1.33B | $1.54B | $1.56B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $10.5M | $36.2M | $72.1M | $34.2M | $24.1M | $73.7M | $109.9M | $68.9M |
